logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
N

Nobuyuki Yamamoto

Department of Upper Gastrointestinal Surgery

73H指数
1.1K论文数
2.9W被引数
收录论文 237
发表时间
logo
Exercise and Cardiorespiratory fitness Improvement through supervised TraINinG in patients undergoing surgery for Upper GastroIntestinal cancer (EXCITING-UGI): study protocol for a randomized controlled trial通过监督训练改善上消化道癌症手术患者运动和心肺适能（EXCITING-UGI）：一项随机对照试验研究方案
errBMC Cancer
IF3.4
err2026-08-31
err0
errOAAI
errTakuya Fukushima; Makoto Yamasaki; Nobuyuki Yamamoto; Eisuke Ochi; Shuntaro Sato; Yuta Yamada; Nao Murai; Hanako Koda; Satoshi Toshiyama; Takashi Harino; Yuki Hashimoto; Masaya Kotsuka; Takuji Sato; Yoshiki Yasukochi; Kentaro Inoue; Koichiro Higasa; Yutaka Kimura; Jiro Nakano
err分享
err收藏
Spatial and graded heterogeneity of GD2 expression in neuroblastoma revealed by whole-slide immunohistochemistry神经母细胞瘤中GD2表达的时空和梯度异质性通过全切片免疫组化揭示
errCancer Immunology Immunotherapy
IF5.1
err2026-07-29
err0
errOAAI
errTomoko Fujikawa; Shotaro Inoue; Akihiro Nishimura; Naoko Nakatani; Nobuyuki Yamamoto; Toshiki Hyodo; Makiko Yoshida; Daiichiro Hasegawa; Kandai Nozu; Akihiro Tamura
err分享
err收藏
Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT3 receptor antagonists and dexamethasone低致呕化疗的抗呕吐疗法系统综述：比较5-HT3受体拮抗剂和地塞米松
errInternational Journal of Clinical Oncology
IF2.8
err2026-07-21
err0
PREAI
errTakeshi Aoyama; Hirotoshi Iihara; Masakazu Abe; Makoto Wada; Keiko Iino; Tatsuo Akechi; Chiyo K. Imamura; Ayako Okuyama; Keiko Ozawa; Yong-Il Kim; Hidenori Sasaki; Eriko Satomi; Masayuki Takeda; Ryuhei Tanaka; Takako Eguchi Nakajima; Naoki Nakamura; Junichi Nishimura; Mayumi Noda; Kazumi Hayashi; Takahiro Higashi; Narikazu Boku; Koji Matsumoto; Yoko Matsumoto; Kenji Okita; Nobuyuki Yamamoto; Kenjiro Aogi
err分享
err收藏
Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab利用数字设备数据开发不可切除III期非小细胞肺癌患者接受度伐利尤米治疗时发生间质性肺病的临床预测模型
errLung Cancer
IF4.4
err2026-05-25
err0
PREAI
errSatoshi Ikeda; Hirotsugu Kenmotsu; Ryo Koto; Takehiro Hirai; Mizue Ogi; Yoshinori Sato; Chikako Iwao; Hiroshi Kitagawa; Nobuyuki Yamamoto
err分享
err收藏
Docetaxel plus ramucirumab immediately after immunotherapy in advanced NSCLC: A phase II study (DRUN)多西他赛联合雷莫芦单抗在免疫治疗后的晚期非小细胞肺癌中的应用：一项II期研究（DRUN）
errLung Cancer
IF4.4
err2026-05-12
err0
errOAAI
errYuhei Harutani; Hiroaki Akamatsu; Takeya Sugimoto; Toshiaki Takakura; Eri Takase; Takahiro Kaki; Katsuyuki Furuta; Ryota Shibaki; Keita Nakaguchi; Seigo Sasaki; Koichi Sato; Yuichi Ozawa; Yusuke Murakami; Atsushi Washioka; Kuninobu Kanai; Ke Wan; Toshio Shimokawa; Nobuyuki Yamamoto
err分享
err收藏
Hydrogen Isotope Exchange in Pyridine Catalyzed by an Iron(II) Imido Complex: Counterion-Directed Regioselectivity吡啶中铁(II)亚胺配合物催化的氢同位素交换：抗衡离子导向的区域选择性
errAngewandte Chemie-International Edition
IF16.9
err2026-04-01
err0
errOAAI
errFeng, Bin; Li, Guorong; Gao, Yafei; Yamamoto, Nobuyuki; Pink, Maren; Peng, Qian; Smith, Jeremy M.
err分享
err收藏
Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M)Ia/Ib期临床试验，评估mobocertinib联合T-DM1在HER2突变实体瘤患者中的安全性和有效性（WJOG16022M）
errEuropean Journal of Cancer
IF7.1
err2026-03-19
err0
errOAAI
errHiroaki Kanemura; Junko Tanizaki; Koji Matsumoto; Toshiki Masuishi; Taichi Isobe; Hirotsugu Kenmotsu; Yu Sunakawa; Toshio Shimizu; Yasutaka Chiba; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Hidetoshi Hayashi
err分享
err收藏
Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapy日本接受高或卡铂为基础的中度致吐风险化疗患者的止吐指南依从性研究
errInternational Journal of Clinical Oncology
IF2.8
err2025-10-15
err0
PREAI
errAyako Okuyama; Takahiro Higashi; Masakazu Abe; Toshinobu Hayashi; Hirotoshi Iihara; Keiko Iino; Chihiro Ishii; Kenji Okita; Makoto Wada; Nobuyuki Yamamoto; Sadamoto Zenda; Kenjiro Aogi; Eriko Satomi
err分享
err收藏
Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study无放疗的帕博利珠单抗联合化疗治疗PD-L1肿瘤比例评分≥50%的局部晚期非小细胞肺癌（Evolution试验）：一项多中心、单臂、Ⅱ期研究
errThe Lancet Oncology
IF0
err2025-10-11
err0
PREAI
errAkito Hata; Taira Ninomaru; Hideaki Okada; Yoshihito Kogure; Masahide Oki; Nobuyuki Katakami; Takashi Kijima; Toshihide Yokoyama; Hirotaka Matsumoto; Yuki Sato; Terufumi Kato; Shunichi Sugawara; Takeshi Sawada; Kenichi Yoshimura; Takashi Seto; Kazuhiko Nakagawa; Isamu Okamoto; Nobuyuki Yamamoto
err分享
err收藏
Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studies布加替尼在克唑替尼治疗后用于ALK阳性非小细胞肺癌患者的疗效与安全性：ALTA-2和J-ALTA研究的综合分析
errLung Cancer
IF4.4
err2025-10-09
err0
PREAI
errTony Mok; Makoto Nishio; Tatsuya Yoshida; Myung-Ju Ahn; Kentarou Kudou; Takayuki Asato; Hui Yang; Xin Tong; Sylvie Vincent; Pingkuan Zhang; Nobuyuki Yamamoto; Edward S. Kim
err分享
err收藏
Genetic analysis of cell-free DNA in follicular lymphoma in comparison with tissue-derived DNA滤泡性淋巴瘤中游离DNA与组织来源DNA的遗传学分析
errLEUKEMIA & LYMPHOMA
IF2.2
err2025-10-01
err0
PREAI
errHori, Yoshikazu; Hosoi, Hiroki; Osuga, Mitsuo; Iwamoto, Ryuta; Maekawa, Fumiyo; Okamura, Tadashi; Murata, Shogo; Mushino, Toshiki; Osato, Motomi; Ohno, Hitoshi; Yamamoto, Nobuyuki; Murata, Shin-Ichi; Koh, Yasuhiro; Takashi, Sonoki
err分享
err收藏
Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutationsEGFR激活突变阳性的非小细胞肺癌患者在接受EGFR酪氨酸激酶抑制剂治疗期间化疗的生物学影响
errLung Cancer
IF4.4
err2025-09-16
err0
errOAAI
errEiji Iwama; Kazuko Sakai; Taishi Harada; Shintaro Kanda; Shunichi Sugawara; Toshihide Yokoyama; Hirokazu Taniguchi; Kaoru Tanaka; Ryo Toyozawa; Kenichi Koyama; Yoshitaka Zenke; Gen Kida; Yasuhiko Nishioka; Hiroshi Yokouchi; Masayuki Hirose; Kazuto Nishio; Nobuyuki Yamamoto; Yuichiro Ohe; Isamu Okamoto
err分享
err收藏
Long-Term Safety and Effectiveness of Durvalumab in Unresectable Stage III non-small cell lung cancer in Japan: A Multicenter Prospective Study (AYAME)日本不可切除性III期非小细胞肺癌中 durvalumab 的长期安全性和有效性：一项多中心前瞻性研究（AYAME）
errJournal of Thoracic Oncology
IF20.8
err2025-08-18
err0
errOAAI
errHirotsugu Kenmotsu; Yoshinobu Saito; Kiichiro Ninomiya; Shinya Uematsu; Burak Akdemir; Ayako Fukui; Ryo Koto; Masakazu Fujiwara; Chikako Iwao; Hiroshi Kitagawa; Ichiro Yoshino; Akihiko Gemma; Tetsuya Mitsudomi; Nobuyuki Yamamoto
err分享
err收藏
Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell lung cancer: REBORN, phase II study (WJOG13520L)度伐利尤单抗联合伊立替康+顺铂用于未经治疗的广泛期小细胞肺癌：REBORN，II期研究（WJOG13520L）
errLung Cancer
IF4.4
err2025-06-29
err0
errOAAI
errMotoko Tachihara; Hiroyasu Shoda; Yuki Akazawa; Takayo Ota; Masahide Oki; Yuki Sato; Shunichi Sugawara; Satoshi Ikeda; Toshihide Yokoyama; Hiroyasu Kaneda; Shoichi Itoh; Akihiro Bessho; Nobuyuki Katakami; Satoshi Morita; Kazuhiko Nakagawa; Isamu Okamoto; Nobuyuki Yamamoto
err分享
err收藏
Phase III study of ramucirumab plus docetaxel versus atezolizumab for previously treated PD-L1 low or negative advanced non-small-cell lung cancer: WJOG10317L study拉姆昔利单抗联合多西他赛对比阿特珠单抗治疗既往接受过治疗的PD-L1低表达或阴性晚期非小细胞肺癌的III期研究：WJOG10317L研究
errLung Cancer
IF4.4
err2025-06-23
err0
PREAI
errYoshitaka Zenke; Seiji Niho; Yukihiro Toi; Masafumi Yamaguchi; Satoshi Hara; Yuki Akazawa; Yukio Hosomi; Kimio Yonesaka; Hiroaki Akamatsu; Toshihide Yokoyama; Junko Tanizaki; Kiyonobu Ueno; Hiroshi Gyotoku; Toshihiro Misumi; Kazuhiko Nakagawa; Nobuyuki Yamamoto; Masahiro Tsuboi
err分享
err收藏
Epidemiology and clinical course of large cell neuroendocrine carcinoma of the lung: The Japanese lung cancer registry study大细胞神经内分泌癌的流行病学与临床病程：日本肺癌登记研究
errLUNG CANCER
IF4.4
err2025-06-01
err0
PREAI
errShirai, Yukina; Shukuya, Takehito; Asao, Tetsuhiko; Takahashi, Kazuhisa; Shintani, Yasushi; Sekine, Ikuo; Takayama, Koichi; Inoue, Akira; Okamoto, Isamu; Kawaguchi, Tomoya; Yamamoto, Nobuyuki; Miyaoka, Etsuo; Yoshino, Ichiro; Date, Hiroshi
err分享
err收藏
Neoadjuvant Concurrent Chemo–Immuno–Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)新辅助同步化免放疗法联合手术及辅助免疫疗法治疗可切除Ⅲ期N2非小细胞肺癌：SQUAT试验（WJOG 12119L）的初步结果
errJournal of Thoracic Oncology
IF20.8
err2025-04-09
err0
PREAI
errAkira Hamada; Junichi Soh; Akito Hata; Kiyoshi Nakamatsu; Mototsugu Shimokawa; Yasushi Yatabe; Jun Suzuki; Masahiro Tsuboi; Hidehito Horinouchi; Yuichi Sakairi; Masayuki Tanahashi; Shinichi Toyooka; Morihito Okada; Natusmi Matsuura; Hisayuki Shigematsu; Yasumasa Nishimura; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Tetsuya Mitsudomi
err分享
err收藏
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2025-03-01
err0
errOAAI
errKogure, Yoshihito; Hashimoto, Hiroya; Daga, Haruko; Fukuda, Yasushi; Bessho, Akihiro; Yamada, Tadaaki; Toi, Yukihiro; Kimura, Tomoki; Yoshioka, Hiroshige; Azuma, Koichi; Furuya, Naoki; Fukui, Yasutaka; Saito, Akiko M.; Yamamoto, Nobuyuki; Saka, Hideo; Kondo, Masashi
err分享
err收藏
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial一线纳武利尤单抗联合铂类化疗和贝伐珠单抗治疗晚期非鳞非小细胞肺癌：TASUKI-52 III期随机试验3年随访
errLUNG CANCER
IF4.4
err2025-03-01
err0
PREAI
errLee, Ki Hyeong; Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru
err分享
err收藏
A Dinuclear Nickel Complex for Electrocatalytic Nitrite Reduction
errINORGANIC CHEMISTRY
IF4.7
err2025-03-01
err0
PREAI
errPartovi, Sheyda; Losovyj, Yaroslav; Yamamoto, Nobuyuki; Smith, Jeremy M.
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
T
Tasuku Honjo
H 指数: 143 · 论文数: 737
J
James Chih‐Hsin Yang
H 指数: 141 · 论文数: 1.2K
Y
Yi‐Long Wu
H 指数: 135 · 论文数: 2.2K
T
Tony Mok
H 指数: 131 · 论文数: 1.1K
G
Gregory J. Riely
H 指数: 127 · 论文数: 1.3K
查看更多